|Access to this symposium is free, but you must first be a
registered FREE ZONE user of HDCN. If not already an HDCN FREE ZONE user, please
register at this link and select a username and password.
| The educational objectives are:|
1. Describe a proactive patient management approach to the treatment of patients with CKD, using the most recent diagnostic and treatment guidelines available to nephrology and other clinical
2. Recognize and discuss the prevalence of CKD and its comorbidities, their clinical implications, and innovative screening programs for identifying CKD and its complications.
Summarize new strategies for the treatment of the anemia of CKD and the effects of anemia correction on both cardiac and renal function.
Adeera Levin, MD|
St Paul's Hospital
University of British Columbia
William McClellan, MD
Emory University School of Medicine
Ajay Singh, MD
Brigham and Women's Hospital
Lawrence McMahon, M.D.
Royal Melbourne and Western Hospitals
Melbourne, Victoria, Australia
This program is accredited
for 1.5 CME credit hours by the American Society of
Nephrology and for 1.5 CE Contact Hours for nurses by the Renal Education Association.
| || Date of Original Release: February 1, 2003|
CME Credit Eligible Through: May 1, 2004
CME/CE Estimated Completion Time: 1.5 hours
Nephrologists, internists, general practicioners, and nurses treating patients with CKD.
Method of participation: Listen to the
talks, read the
PubMed abstracts linked to data slides and talk references, take
the post-test, read the post-test answer feedback material, and complete the
evaluation form. CME/CE certificates are provided on-line after completion.
Chronic kidney disease affects 30-40 million Americans, of
thousand require renal replacement therapy. These selected lectures
by the HDCN editor and ASN Postgraduate Medical Director to reflect
of practice of greatest interest to the clinician, and areas where
has occurred. The web extension of these ASN lectures will
and other physicians who were unable to attend the live sessions to
benefit from these presentations.
The American Society of Nephrology is accredited by
Council for Continuing Medical Education to provide continuing
The Renal Education Association is accredited by the State of California Board of Nursing to provide continuing education for nurses (provider number: CEP 13092).
The American Society of Nephrology designates this
for category 1.5 credits toward the AMA Physician's Recognition Award.
should claim only those hours of credit that he/she actually spent
in the activity.
This official ASN symposium was sponsored by a restricted educational grant from Ortho Biotech Products, LP.
American Society of Nephrology, the Renal Education
Association, as well
as HDCN have conflict of interest policies that requires course
faculty to disclose
any real or apparent commercial financial affiliations related to
of their presentations/materials. It is not assumed that these
or affiliations will have an adverse impact on faculty
presentations; they are
simply noted here to fully inform participants.
| FACULTY DISCLOSURE
Dr. Levin: Has grants, research support, consultantships, board positions or honoraria from: Ortho Biotch Products, L.P., Amgen, Genzyme, Roche, and Merck
Dr. McClellan: is a clinical investigator for Ortho Biotech Products, L.P.
Dr. Singh: Has grants, research support, consultantships, board positions, or honoraria from: Ortho Biotech Products, L.P., CHOIR Study Principal Investigator, Pfizer, DCI Medical Director and
Sherine Medical. He is also a scientific
advisor for FlowMedica and Sherine Medical.
Dr. McMahon: Has grants, research support, or honoraria from: Janssen-Cilag, Ortho Biotech Products, L.P. and Amgen. He is also a scientific advisor for Janssen-Cilag and Ortho Biotech Products,
This educational activity may contain discussion of
investigational uses of agents that are not indicated by FDA. The
of Nephrology, the Renal Education Association, and HDCN do not
use of any agent outside of the labeled indications. Please refer
to the official
prescribing information for each product for discussion of approved
contraindications and warnings.
| DISCLOSURE OF
Participants have an implied responsibility to use the
information to enhance patient outcomes and their own professional
The information presented in this activity is not meant to serve as
for patient management. Any procedures, medications, or other
courses of diagnosis
or treatment discussed or suggested in this activity should not be
used by clinicians
without evaluation of their patient's conditions and possible
on dangers in use, review of any applicable manufacturer's product
and comparison with recommendations of other authorities.
To complete this educational activity, the user will need Windows or Macintosh operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or
the Real Player from Real Media (www.real.com) is required and either can be downloaded for free
per instructions on the individual lecture pages. Acrobat Reader is required to print the CME or
CE certificate, and this can be download free from www.adobe.com.
For any questions concerning this activity please send an email to
or call HDCN at 630-325-3276.